Experimental painkiller could outsmart opioids -- without the high

Pain Control News

Experimental painkiller could outsmart opioids -- without the high
NeuropathyPharmacologyFibromyalgia
  • 📰 ScienceDaily
  • ⏱ Reading Time:
  • 217 sec. here
  • 12 min. at publisher
  • 📊 Quality Score:
  • News: 114%
  • Publisher: 53%

A study shows a non-opioid pain reliever blocks pain at its source -- calming specific nerve signals that send pain messages to the brain. In mice, the compound SBI-810 eased pain from surgery, bone fractures, and nerve injury without causing sedation or constipation.

A study shows a non-opioid pain reliever blocks pain at its source -- calming specific nerve signals that send pain messages to the brain. In mice, the compound SBI-810 eased pain from surgery, bone fractures, and nerve injury without causing sedation or constipation.

An experimental drug developed at Duke University School of Medicine could offer powerful pain relief without the dangerous side effects of opioids. The drug, called SBI-810, is part of a new generation of compounds designed to target a receptor on the nerves and spinal cord. While opioids flood multiple cellular pathways indiscriminately, SBI-810, a non-opioid treatment, takes a more focused approach, activating only a specific pain-relief pathway that avoids the euphoric"high" linked to addiction. In tests in mice, SBI-810 worked well on its own and, when used in combination, made opioids more effective at lower doses, according to the study published May 19 in"What makes this compound exciting is that it is both analgesic and non-opioid," said senior study author Ru-Rong Ji, PhD, an anesthesiology and neurobiology researcher who directs the Duke Anesthesiology Center for Translational Pain Medicine. Even more encouraging: it prevented common side effects like constipation and buildup of tolerance, which often forces patients to need stronger and more frequent doses of opioids over time. SBI-810 is in early development, but Duke researchers are aiming for human trials soon and they've locked in multiple patents for the discovery. There's an urgent need for pain relief alternatives. Drug overdose deaths are declining, but more than 80,000 Americans still die each year most often from opioids. Meanwhile, chronic pain affects one-third of the U.S. population. Researchers said the drug could be a safer option for treating both short-term and chronic pain for those recovering from surgery or living with diabetic nerve pain. SBI-810 is designed to target the brain receptor neurotensin receptor 1. Using a method known as biased agonism, it switches on a specific signal -- β-arrestin-2 -- linked to pain relief, while avoiding other signals that can cause side effects or addiction. "The receptor is expressed on sensory neurons and the brain and spinal cord," Ji said."It's a promising target for treating acute and chronic pain." SBI-810 effectively relieved pain from surgical incisions, bone fractures, and nerve injuries better than some existing painkillers. When injected in mice, it reduced signs of spontaneous discomfort, such as guarding and facial grimacing. Duke scientists compared SBI-810 to oliceridine, a newer type of opioid used in hospitals, and found SBI-810 worked better in some situations, with fewer signs of distress. Unlike opioids like morphine, SBI-810 didn't cause tolerance after repeated use. It also outperformed gabapentin, a common drug for nerve pain, and didn't cause sedation or memory problems, which are often seen with gabapentin. Researchers said the compound's dual action -- on both the peripheral and central nervous systems -- could offer a new kind of balance in pain medicine: powerful enough to work, yet specific enough to avoid harm.Additional Duke authors include first authors Ran Guo and Ouyang Chen; Sangsu Bang, Sharat Chandra, Yize Li, Gang Chen, Rou-Gang Xie, Wei He, Jing Xu, Richard Zhou, Shaoyong Song, Ivan Spasojevic, Marc G. Caron, William C. Wetsel and Lawrence S. Barak.??Ran Guo, Ouyang Chen, Yang Zhou, Sangsu Bang, Sharat Chandra, Yize Li, Gang Chen, Rou-Gang Xie, Wei He, Jing Xu, Richard Zhou, Shaoyong Song, Kelsey L. Person, Madelyn N. Moore, Abigail R. Alwin, Ivan Spasojevic, Michael R. Jackson, Steven H. Olson, Marc G. Caron, Lauren M. Slosky, William C. Wetsel, Lawrence S. Barak, Ru-Rong Ji.A new study shows that a toxin from the microbe that causes anthrax can silence multiple types of pain in mice. Researchers found the toxin targets pain-sensing cells to alter signaling and block ... Opioid medications remain a go-to treatment for severe pain, whether it's from surgery, a sudden injury, or nerve damage. But as opioid addiction and overdose deaths reach new highs in the United ... Researchers at the University of Arizona Health Sciences are closer to developing a safe and effective non-opioid pain reliever after a study showed that a new compound they created reduces the ... A gene therapy for chronic pain could offer a safer, non-addictive alternative to opioids. Researchers have developed the new therapy, which works by temporarily repressing a gene involved in sensing ...

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

ScienceDaily /  🏆 452. in US

Neuropathy Pharmacology Fibromyalgia Brain Injury Opium Caregiving Addiction

 

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

David Thomas, frontman of experimental rockers Pere Ubu, dead at 71David Thomas, frontman of experimental rockers Pere Ubu, dead at 71David Thomas, the live-wire frontman for experimental rockers Pere Ubu, has died. He was 71.
Read more »

Experimental Drug Tested in Mice Repairs The Eye to Restore VisionExperimental Drug Tested in Mice Repairs The Eye to Restore VisionThe Best in Science News and Amazing Breakthroughs
Read more »

Experimental quantum communications networkExperimental quantum communications networkResearchers recently connected their campuses with an experimental quantum communications network using two optical fibers.
Read more »

Montana Becomes the Right to Try Anything State, Expanding Access to Experimental DrugsMontana Becomes the Right to Try Anything State, Expanding Access to Experimental DrugsSB 535 formally paves the way for health care clinics to become 'experimental treatment centers' that can provide drugs still in development to willing patients.
Read more »

How an experimental gene editing treatment helped a desperately ill babyHow an experimental gene editing treatment helped a desperately ill babyThe nine-month-old boy suffers of a rare genetic disease, but now thanks to an experimental gene editing treatment, he is now on the road to recovery.
Read more »

Experimental drones developed to neutralize mass shooters, disable weaponsExperimental drones developed to neutralize mass shooters, disable weaponsThe next generation of policing is rising up in the Chicago area with drones that answer 911 calls on their own and an experimental drone system designed to stop would-be mass shooters, the ABC7 I-Team has learned.
Read more »



Render Time: 2026-04-01 09:07:32